Amherst Fund

Fusion Coolant Systems, Inc. specializes in manufacturing and marketing advanced coolant and lubrication systems for the manufacturing industry, utilizing supercritical carbon dioxide technology. The company offers products such as Pure-Cut 1000 and LUBE-CUT 1600, which deliver supercritical CO2 with varying lubrication rates for different cutting applications. These systems enhance production rates and extend tool life while addressing the shortcomings of traditional metalworking fluids, which can pose health and environmental risks. Fusion Coolant's innovative CHiP Lube system significantly outperforms conventional methods, reducing costs and eliminating toxic waste. The company's products find applications in various sectors, including medical implants, aerospace, automotive, and power generation. Fusion Coolant Systems, founded in 2009 and based in Canton, Michigan, also maintains an office in Saint-Priest, France, and has a strategic partnership with Air Liquide.

Fusion Coolant Systems, Inc. specializes in manufacturing and marketing advanced coolant and lubrication systems for the manufacturing industry, utilizing supercritical carbon dioxide technology. The company offers products such as Pure-Cut 1000 and LUBE-CUT 1600, which deliver supercritical CO2 with varying lubrication rates for different cutting applications. These systems enhance production rates and extend tool life while addressing the shortcomings of traditional metalworking fluids, which can pose health and environmental risks. Fusion Coolant's innovative CHiP Lube system significantly outperforms conventional methods, reducing costs and eliminating toxic waste. The company's products find applications in various sectors, including medical implants, aerospace, automotive, and power generation. Fusion Coolant Systems, founded in 2009 and based in Canton, Michigan, also maintains an office in Saint-Priest, France, and has a strategic partnership with Air Liquide.

Filament builds blockchain hardware and& software solutions for enterprise and IoT. Filament’s distributed blockchain capabilities leverage open protocols so that devices are able to independently process and record transactions, ensuring digital trust. Its new trusted application software and Blocklet Chip, currently in beta, are designed to communicate and interact with multiple blockchain technologies natively. The software, implemented on existing hardware, will deliver a secure distributed ledger technology solution. The Blocklet Chip will allow industrial corporations and enterprises to seamlessly extract the value of recording and monetizing data assets, at the edge of the network, on the sensors themselves.

Sierra Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer, particularly in the fields of hematology and oncology. Its lead candidate, momelotinib, is a selective JAK1, JAK2, and ACVR1 inhibitor that has been evaluated in two Phase 3 trials for myelofibrosis. The company is also advancing SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, currently undergoing two Phase 1/2 clinical trials to explore its potential as a monotherapy and in combination with other therapies. Additionally, Sierra is developing SRA141, a small molecule inhibitor of cell division cycle 7 kinase, which is in preclinical research stages. Founded in 2003 and headquartered in Vancouver, Canada, Sierra Oncology retains global commercialization rights for its product candidates and aims to achieve successful registration and commercialization of its innovative therapies targeting the DNA Damage Response network.

Filament builds blockchain hardware and& software solutions for enterprise and IoT. Filament’s distributed blockchain capabilities leverage open protocols so that devices are able to independently process and record transactions, ensuring digital trust. Its new trusted application software and Blocklet Chip, currently in beta, are designed to communicate and interact with multiple blockchain technologies natively. The software, implemented on existing hardware, will deliver a secure distributed ledger technology solution. The Blocklet Chip will allow industrial corporations and enterprises to seamlessly extract the value of recording and monetizing data assets, at the edge of the network, on the sensors themselves.

Fusion Coolant Systems, Inc. specializes in manufacturing and marketing advanced coolant and lubrication systems for the manufacturing industry, utilizing supercritical carbon dioxide technology. The company offers products such as Pure-Cut 1000 and LUBE-CUT 1600, which deliver supercritical CO2 with varying lubrication rates for different cutting applications. These systems enhance production rates and extend tool life while addressing the shortcomings of traditional metalworking fluids, which can pose health and environmental risks. Fusion Coolant's innovative CHiP Lube system significantly outperforms conventional methods, reducing costs and eliminating toxic waste. The company's products find applications in various sectors, including medical implants, aerospace, automotive, and power generation. Fusion Coolant Systems, founded in 2009 and based in Canton, Michigan, also maintains an office in Saint-Priest, France, and has a strategic partnership with Air Liquide.